Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Trending Product / SARS-CoV-2

Recombinant SARS-CoV-2 NSP3/PL-PRO Protein, N-His

Catalog #:   YVV01202 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0DTD1
Protein length: Glu1564-Ile1877
Overview

Catalog No.

YVV01202

Expression system

E. coli

Species

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protein length

Glu1564-Ile1877

Predicted molecular weight

38.59 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>85% as determined by SDS-PAGE.

Accession

P0DTD1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Non-structural protein 3, nsp3, PL2-PRO, Papain-like protease, Papain-like proteinase, PL-PRO, Replicase polyprotein 1ab, pp1ab, ORF1ab polyprotein

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant SARS-CoV-2 NSP3 / PL-PRO
References

Genome-Wide Interrogation of SARS-CoV-2 RNA-Protein Interactions Uncovers Hidden Regulatory Sites., PMID:40501555

Defining short linear motif binding determinants by phage display-based deep mutational scanning., PMID:40411416

Identification of a series of pyrrolo-pyrimidine-based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication., PMID:40407321

Structural and functional insights into the SARS-CoV-2 SUD domain and its interaction with RNA G-Quadruplexes., PMID:40252399

The SARS-CoV-2 NSP4 T492I mutation promotes double-membrane vesicle formation to facilitate transmission., PMID:40157604

Comparative Interactome Profiling of Nonstructural Protein 3 Across SARS-CoV-2 Variants Emerged During the COVID-19 Pandemic., PMID:40143373

Derivatives of MOPS: promising scaffolds for SARS coronaviruses Macro domain-targeted inhibition., PMID:40070175

Evaluation of Genomic Surveillance of SARS-CoV-2 Virus Isolates and Comparison of Mutational Spectrum of Variants in Bangladesh., PMID:40006937

Exploring natural compounds and synthetic derivatives as potential inhibitors of SARS-CoV-2 PLpro: a computational approach with enzyme inhibition and cytotoxicity assessment., PMID:39972932

Torsional twist of the SARS-CoV and SARS-CoV-2 SUD-N and SUD-M domains., PMID:39969084

Orchestration of SARS-CoV-2 Nsp4 and host cell ESCRT proteins induces morphological changes of the endoplasmic reticulum., PMID:39937675

A comprehensive review of current insights into the virulence factors of SARS-CoV-2., PMID:39878471

Investigation of Immunoreactivity Profiles and Epitope Landscape in Divergent COVID-19 Trajectories and SARS-CoV-2 Variants., PMID:39873496

Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis., PMID:39755743

SARS-CoV-2 NSP3/4 control formation of replication organelle and recruitment of RNA polymerase NSP12., PMID:39737877

Regulation of N-degron recognin-mediated autophagy by the SARS-CoV-2 PLpro ubiquitin deconjugase., PMID:39723606

Proteome-Wide Analysis of Antibody Responses in Asymptomatic Omicron BA.2-Infected Individuals at the Amino Acid Resolution., PMID:39661118

SARS-CoV-2 N protein recruits G3BP to double membrane vesicles to promote translation of viral mRNAs., PMID:39638802

Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses., PMID:39599890

Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Nonstructural Protein Inhibitors., PMID:39574309

Phylogeogenomic analysis of the earliest reported sequences of SARS-CoV-2 from 161 countries., PMID:39563179

Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication., PMID:39554145

Mutational and evolutionary dynamics of non-structural and spike proteins from variants of concern (VOC) of SARS-CoV-2 in India., PMID:39488303

MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients., PMID:39460899

Investigating TCR-pMHC interactions for TCRs without identified epitopes by constructing a computational pipeline., PMID:39423970

The SARS-unique domain (SUD) of SARS-CoV-2 nsp3 protein inhibits the antiviral immune responses through the NF-κB pathway., PMID:39400381

The CoV-Y domain of SARS-CoV-2 Nsp3 interacts with BRAP to stimulate NF-κB signaling and induce host inflammatory responses., PMID:39343285

N terminus of SARS-CoV-2 nonstructural protein 3 interrupts RNA-driven phase separation of N protein by displacing RNA., PMID:39341499

SARS-CoV-2 Genotyping Highlights the Challenges in Spike Protein Drift Independent of Other Essential Proteins., PMID:39338537

The impact of host microRNAs on the development of conserved mutations of SARS-CoV-2., PMID:39333651

A Novel Self-Amplifying mRNA with Decreased Cytotoxicity and Enhanced Protein Expression by Macrodomain Mutations., PMID:39313862

Prediction of the effects of the top 10 synonymous mutations from 26645 SARS-CoV-2 genomes of early pandemic phase., PMID:39268187

Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning., PMID:39253507

Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening., PMID:39229067

Emergence of crucial evidence catalyzing the origin tracing of SARS-CoV-2., PMID:39213297

Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends., PMID:39205305

ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis., PMID:39194248

Torsional Twist of the SARS-CoV and SARS-CoV-2 SUD-N and SUD-M domains., PMID:39185168

ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis., PMID:39149229

Molecular architecture of coronavirus double-membrane vesicle pore complex., PMID:39143215

Oxysterole-binding protein targeted by SARS-CoV-2 viral proteins regulates coronavirus replication., PMID:39119292

[Self-assembly of the C-terminal and transmembrane region of the SARS-CoV-2 protein nsp3]., PMID:38986091

Synthesis of Structural ADP-Ribose Analogues as Inhibitors for SARS-CoV-2 Macrodomain 1., PMID:38935522

Natural-Target-Mimicking Translocation-Based Fluorescent Sensor for Detection of SARS-CoV-2 PLpro Protease Activity and Virus Infection in Living Cells., PMID:38928340

Progressive Evolutionary Dynamics of Gene-Specific ω Led to the Emergence of Novel SARS-CoV-2 Strains Having Super-Infectivity and Virulence with Vaccine Neutralization., PMID:38928018

Investigating SARS-CoV-2 virus-host interactions and mRNA expression: Insights using three models of D. melanogaster., PMID:38925484

Immunoinformatic of novel self-amplifying mRNA vaccine lipid nanoparticle against SARS-CoV-2., PMID:38903554

Mutation prediction in the SARS-CoV-2 genome using attention-based neural machine translation., PMID:38872567

PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation., PMID:38834852

Nanoscale cellular organization of viral RNA and proteins in SARS-CoV-2 replication organelles., PMID:38821943

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant SARS-CoV-2 NSP3/PL-PRO Protein, N-His [YVV01202]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only